[Form 4] Community Healthcare Trust Incorporated Insider Trading Activity

Rhea-AI Filing Summary

Community Healthcare Trust's Executive Vice President & CFO William G. Monroe IV acquired 29,009 shares on 08/07/2025 as restricted stock equal to 50% of his 2025 cash bonus, using the 10‑day average price of $15.85. The award carries an eight‑year restriction period and increases Mr. Monroe's direct beneficial ownership to 190,201 shares. The filing reports this compensation election and the derived share price calculation based on the company's 10 trading‑day average immediately preceding the transaction.

Positive

• Executive elected to receive 50% of his 2025 cash bonus in restricted stock, demonstrating a compensation choice that increased his direct holdings to 190,201 shares.
• Price determination disclosed: the acquisition used the 10‑day average price of $15.85, providing transparency on valuation of the award.

Negative

• None.

Insights

Compensation Analyst

TL;DR: CFO converted half of his 2025 bonus into restricted stock—29,009 shares at a $15.85 10‑day average—raising direct holdings to 190,201 shares.

This transaction is a routine executive compensation election disclosed on Form 4. The reporting shows a 50% cash‑bonus election into restricted stock with an eight‑year restriction, and the grant price was set using the 10‑day average prior to the transaction date. For investors, the important facts are the share count, the lengthy restriction period and that the shares are recorded as direct beneficial ownership; the filing does not disclose any change in option grants, cash compensation amounts or the companywide share count.

Corporate Governance Expert

TL;DR: Long restriction period (eight years) on bonus‑converted stock is notable for governance and retention, but the filing shows no other material change.

The disclosure documents an executive's compensation election rather than a market transaction for trading purposes. The eight‑year restriction period is explicitly stated and may influence the executive's long‑term alignment with shareholders, though the filing itself provides no additional governance actions or changes to board composition. All conclusions are based solely on the reported grant amount, price methodology and stated restriction term.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monroe William G. IV

(Last) (First) (Middle)

3326 ASPEN GROVE DRIVE, SUITE 150

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Community Healthcare Trust Inc [ CHCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2025		A		29,009(1)	A	$15.85	190,201	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. For 2025, the reporting person agreed to take 50% of his cash bonus in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take 50% of his bonus for 2025 in shares of restricted stock with an eight-year restriction period, the Company awarded Mr. Monroe additional compensation, in restricted stock, equal to 50% of his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 7, 2025, which was $15.85.

Remarks:

	/s/ Nathanael P. Kibler, Attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CHCT insider William G. Monroe IV report on Form 4?

He acquired 29,009 shares on 08/07/2025 as restricted stock equal to 50% of his 2025 cash bonus at a $15.85 10‑day average price, bringing his direct holdings to 190,201 shares.

Why were the 29,009 shares issued to the CHCT CFO?

Mr. Monroe elected to take 50% of his 2025 cash bonus in restricted stock with an eight‑year restriction period, per the Form 4 explanation.

What price was used to value the restricted stock reported for CHCT?

The price was $15.85, calculated as the average price of the company's common stock for the 10 trading days immediately preceding August 7, 2025.

How many CHCT shares does William Monroe directly own after this transaction?

190,201 shares of Common Stock are reported as beneficially owned following the reported transaction.

What is the restriction period on the shares acquired by the CHCT CFO?

An eight‑year restriction period applies to the restricted stock acquired as part of his 2025 bonus election.